Gilteritinib

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 522 publications

Targeting FLT-3 Mutations in Acute Myeloid Leukaemia: from Molecular Insights to Clinical Strategies.

Targeting FLT-3 Mutations in Acute Myeloid Leukaemia: from Molecular Insights to Clinical Strategies.

Journal: Folia biologica
Published: April 14, 2026

Venetoclax plus azacitidine as successful bridging therapy to second transplantation for post-transplant extramedullary relapse of acute myeloid leukemia

Venetoclax plus azacitidine as successful bridging therapy to second transplantation for post-transplant extramedullary relapse of acute myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 04, 2026

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions.

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions.

Journal: Journal of personalized medicine
Published: February 16, 2026

Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemia.

Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemia.

Journal: Transplantation and cellular therapy
Published: February 14, 2026

Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era.

Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era.

Journal: Clinical lymphoma, myeloma & leukemia
Published: February 08, 2026

A Modified-Delphi Consensus on the Management of Patients with FLT3-Mutated AML.

A Modified-Delphi Consensus on the Management of Patients with FLT3-Mutated AML.

Journal: Cancers
Published: January 23, 2026

Real-world patterns of maintenance therapy after allogeneic transplant in older adults with acute myeloid leukemia: A Medicare cohort study.

Real-world patterns of maintenance therapy after allogeneic transplant in older adults with acute myeloid leukemia: A Medicare cohort study.

Journal: Journal of geriatric oncology
Published: January 20, 2026

Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies.

Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies.

Journal: The Journal of antimicrobial chemotherapy
Published: January 19, 2026

Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib.

Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib.

Journal: Haematologica
Published: January 14, 2026

Management of Acute Myeloid Leukemia: A Review.

Management of Acute Myeloid Leukemia: A Review.

Journal: Cancers
Published: January 13, 2026

Differentiation Syndrome in Acute Myeloid Leukemia: Molecular Mechanisms, Clinical Spectrum, and Emerging Therapeutic Paradigms.

Differentiation Syndrome in Acute Myeloid Leukemia: Molecular Mechanisms, Clinical Spectrum, and Emerging Therapeutic Paradigms.

Journal: International journal of molecular sciences
Published: December 29, 2025

A case of intestinal tumor formation during gilteritinib therapy that resolved without discontinuing the drug.

A case of intestinal tumor formation during gilteritinib therapy that resolved without discontinuing the drug.

Journal: Clinical journal of gastroenterology
Published: December 13, 2025
Showing 1-12 of 522

Last Updated: 04/28/2026